Study to Evaluate the Safety, Tolerability, and Blood Pressure Effect of an Oral Dose of Sumatriptan Alone and in Combination With MK-0974 (Telcagepant) in Migraine Patients (0974-026)

NCT00701389 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine Disorders

Interventions

DRUG: telcagepant potassium
DRUG: sumatriptan
DRUG: sumatriptan placebo
DRUG: telcagepant potassium placebo

Sponsor

Merck Sharp & Dohme LLC